ANRO

Alto Neuroscience, Inc.

Company with tickers: ANRO

Market Cap

$948.94M

Shares Outstanding

35,093,940

CIK

1999480

CUSIP

02157Q109

13F Activity (30d)

1 filings 1 filers

Website

Visit website

Investor Relations

Investor relations

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-15	Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia
2026-05-28	Alto Neuroscience Appoints Karuna Therapeutics Founder Andrew Miller, Ph.D. to Board of Directors
2026-05-15	Alto Neuroscience CEO Amit Etkin, M.D., Ph.D. Receives Columbia University Transformational Research Award
2026-05-13	Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
2026-05-11	Alto Neuroscience Announces Participation in Upcoming Investor Conferences
2026-04-21	Alto Neuroscience Initiates Phase 2b Trial of ALTO-207 in Treatment-Resistant Depression
2026-04-01	Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
2026-03-16	Alto Neuroscience Announces $120 Million Private Placement Financing
2026-03-16	Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights
2026-03-13	Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum
2026-02-23	Alto Neuroscience Announces Participation in Upcoming Investor Conferences

Past events

Date	Event	Type
2026-06-16	H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit (Hybrid)	Event
2026-06-03	Jefferies Global Healthcare Conference	Conference
2026-05-13	Bank of America Securities Healthcare Conference	Conference
2026-03-17	2026 Stifel CNS Forum	Event
2026-03-10	Jefferies 2026 Biotech on the Beach Summit	Event
2026-03-02	TD Cowen 46th Annual Healthcare Conference	Conference
2025-11-17	Jefferies London Healthcare Conference	Conference
2025-11-12	Stifel 2025 Healthcare Conference	Conference
2025-09-17	TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit	Event
2025-09-09	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-06-17	H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference	Conference
2025-06-05	Jefferies Global Healthcare Conference	Conference
2025-06-03	Alto Neuroscience, Inc. - Investor Call	Event
2025-04-29	JonesResearch Virtual CNS Day	Event
2025-03-18	Stifel 2025 Virtual CNS Forum	Event
2025-03-12	Leerink's Global Healthcare Conference 2025	Conference
2025-03-04	TD Cowen 45th Annual Health Care Conference	Conference
2024-11-20	Jefferies London Healthcare Conference	Conference
2024-11-18	Stifel 2024 Healthcare Conference	Conference
2024-09-26	TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit	Event
2024-09-17	2024 Cantor Global Healthcare Conferenc	Event
2024-09-09	Investor Day Focused on Upcoming ALTO-100 Phase 2b Readout in MDD	Presentation
2024-06-06	Jefferies Global Healthcare Conference	Conference
2024-03-20	Stifel 2024 Virtual CNS Days	Event
2024-03-18	UBS Virtual CNS Day 2024	Event

Source: https://investors.altoneuroscience.com/overview/default.aspx